PT Inquest is an online journal club. Hosted by Jason Tuori, Megan Graham, and Chris Juneau, the show looks at an article every week and discusses how it applies to current physical therapy practice.
…
continue reading
Content provided by Dr Neil Love. All podcast content including episodes, graphics, and podcast descriptions are uploaded and provided directly by Dr Neil Love or their podcast platform partner. If you believe someone is using your copyrighted work without your permission, you can follow the process outlined here https://player.fm/legal.
Player FM - Podcast App
Go offline with the Player FM app!
Go offline with the Player FM app!
Head and Neck Cancer | What I Tell My Patients: Integrating New Research Information into Current Clinical Care — Head and Neck Cancer
QUICKTIME•Episode home
Manage episode 421381970 series 1464173
Content provided by Dr Neil Love. All podcast content including episodes, graphics, and podcast descriptions are uploaded and provided directly by Dr Neil Love or their podcast platform partner. If you believe someone is using your copyrighted work without your permission, you can follow the process outlined here https://player.fm/legal.
Featuring perspectives from Ms Meetal Dharia, Dr Robert L Ferris, Dr Robert Haddad and Ms Lynsey P Teulings, including the following topics:
- Introduction (0:00)
- The Biology of Head and Neck Cancer (15:41)
- The Multidisciplinary Treatment of Head and Neck Cancer (18:14)
- Ongoing Screening and Prevention After Potentially Curative Therapy for Head and Neck Cancer (33:03)
- Radiation Therapy and Chemotherapy Side Effects (41:02)
- The Potential Short- and Long-Term Effects of Surgery for Head and Neck Cancer (49:50)
- Emerging Treatment Strategies Aimed at Improving Outcomes Associated with Localized or Locally Advanced Head and Neck Cancer (56:46)
- Tolerability Considerations with Xevinapant (1:06:13)
- The Established Role of Anti-PD-1/PD-L1 Antibodies in Therapy for Advanced Head and Neck Cancer (1:17:35)
- Newly Approved Immunotherapeutic Strategies for Nasopharyngeal Carcinoma (1:19:27)
- The Tolerability of Immune Checkpoint Inhibitors (1:24:09)
1412 episodes
QUICKTIME•Episode home
Manage episode 421381970 series 1464173
Content provided by Dr Neil Love. All podcast content including episodes, graphics, and podcast descriptions are uploaded and provided directly by Dr Neil Love or their podcast platform partner. If you believe someone is using your copyrighted work without your permission, you can follow the process outlined here https://player.fm/legal.
Featuring perspectives from Ms Meetal Dharia, Dr Robert L Ferris, Dr Robert Haddad and Ms Lynsey P Teulings, including the following topics:
- Introduction (0:00)
- The Biology of Head and Neck Cancer (15:41)
- The Multidisciplinary Treatment of Head and Neck Cancer (18:14)
- Ongoing Screening and Prevention After Potentially Curative Therapy for Head and Neck Cancer (33:03)
- Radiation Therapy and Chemotherapy Side Effects (41:02)
- The Potential Short- and Long-Term Effects of Surgery for Head and Neck Cancer (49:50)
- Emerging Treatment Strategies Aimed at Improving Outcomes Associated with Localized or Locally Advanced Head and Neck Cancer (56:46)
- Tolerability Considerations with Xevinapant (1:06:13)
- The Established Role of Anti-PD-1/PD-L1 Antibodies in Therapy for Advanced Head and Neck Cancer (1:17:35)
- Newly Approved Immunotherapeutic Strategies for Nasopharyngeal Carcinoma (1:19:27)
- The Tolerability of Immune Checkpoint Inhibitors (1:24:09)
1412 episodes
All episodes
×Welcome to Player FM!
Player FM is scanning the web for high-quality podcasts for you to enjoy right now. It's the best podcast app and works on Android, iPhone, and the web. Signup to sync subscriptions across devices.